Clinical Trial

A Phase 2 Study Of Zanzalintinib For Patients With Recurrent Or Metastatic Olfactory Neuroblastoma

Name: A Phase 2 Study Of Zanzalintinib For Patients With Recurrent Or Metastatic Olfactory Neuroblastoma — clinical trial record (NCT07527169)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The goal of this clinical research study is to learn if zanzalintinib can help to control recurrent/metastatic ONB. The safety of zanzalintinib will also be studied.

Trial Details

NCT Number	NCT07527169
Lead Sponsor	M.D. Anderson Cancer Center
Conditions	Metastatic Olfactory Neuroblastoma
Enrollment	16 participants
Start Date	2026-10-01
Primary Completion	2028-07-01 (estimated)
Study Completion	2030-07-01 (estimated)
Updated on ClinicalTrials.gov	2026-08-12